StockNews.com lowered shares of Sabre (NASDAQ:SABR – Free Report) from a buy rating to a hold rating in a research note published on Wednesday.
Sabre Stock Performance
Shares of SABR opened at $3.69 on Wednesday. The business has a 50-day moving average of $3.43 and a 200 day moving average of $3.13. Sabre has a fifty-two week low of $1.81 and a fifty-two week high of $4.68. The firm has a market cap of $1.42 billion, a P/E ratio of -4.67 and a beta of 1.74.
Sabre (NASDAQ:SABR – Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The information technology services provider reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.01. The firm had revenue of $764.71 million during the quarter, compared to analysts’ expectations of $774.53 million. During the same period last year, the business posted ($0.10) EPS. The company’s revenue was up 3.3% compared to the same quarter last year. As a group, research analysts predict that Sabre will post -0.3 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Sabre Company Profile
Sabre Corporation, together with its subsidiaries, operates as software and technology company for travel industry in the United States, Europe, Asia-Pacific, and internationally. It operates through two segments: Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments.
See Also
- Five stocks we like better than Sabre
- Differences Between Momentum Investing and Long Term Investing
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- Technology Stocks Explained: Here’s What to Know About Tech
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Receive News & Ratings for Sabre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabre and related companies with MarketBeat.com's FREE daily email newsletter.